Felbamate increases [3H]glycine binding in rat brain and sections of human postmortem brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 991-999

  McCabe, R Tyler ^a   Sofia, R Duane ^b   Layer, Richard T ^a   Leiner, Kevin A ^c   Faull, Richard L M ^d   Narang, Neelam ^e   Wamsley, James K ^f  

^a Cognetix Inc ^*  (United States)

^b Wallace Laboratories   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

^f NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,7 DICHLOROKYNURENIC ACID; FELBAMATE; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; 5,7-DICHLOROKYNURENIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; GLYCINE RECEPTOR; KYNURENIC ACID; PROPANEDIOL DERIVATIVE;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING COMPETITION; BRAIN TISSUE; CADAVER; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN TISSUE; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; ANIMAL; AUTORADIOGRAPHY; BRAIN LEVEL; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; ANTICONVULSANTS; AUTORADIOGRAPHY; BRAIN CHEMISTRY; EXCITATORY AMINO ACID ANTAGONISTS; GLYCINE; HUMANS; KYNURENIC ACID; MALE; POSTMORTEM CHANGES; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032219622     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. 3H]5,7-Dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. Eur J Pharmacol 206:149-154.
2. Bourgeois BFD, Leppik IE, Sackellares JC, Lesser RP, Laxer KD, Messenheimer JA, Kramer LD, Rosenberg AR and Kamin M (1993) Felbamate: A double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 43:693-696.
3. Burdette DE, Zheng C, Tornow MA, Olson LD and Sackellares JC (1992) Felbamate reduces atypical generalized spike wave discharges in patients with Lennox-Gastaut syndrome. Neurology 42:330-335.
4. Carter AJ (1992) Glycine antagonists: Regulation of the NMDA receptor-channel complex by the strychnine-insensitive glycine site. Drugs Future 17:595-613.
5. Coffin V, Cohen-Williams M and Barnett A (1994) Selective antagonism of the anticonvulsant effects of felbamate by glycine. Eur J Pharmacol 256:R9-R10.
6. De Sarro G, Ongini E, Bertorelli R, Aguglia U and De Sarro A (1994) Excitatory amino acid transmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. Eur J Pharmacol 262:11-19.
7. Faught E, Sachdeo RC, Remler MR, Chayasirisobhon S, Ramsay R, Iragui V, Kaner A, Kramer LD and Rosenberg A (1993) Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology 43:688-692.
8. Kleckner NW and Dingledine RD (1988) Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 241:835-837.
9. Kutsuwada T, Kashiwabuchi N, Mori X, Sakimura X, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M and Mishina M (1992) Molecular diversity of the NMDA receptor channel. Nature (Lond) 358:36-41.
10. Leppik IE, Dreifuss FE, Pledger GW, Graves NM, Santilli N, Drury I, Tsay JY, Jacobs MP, Bertram E, Cereghino JJ, Cooper G, Sahlrrot JT, Sheridan P, Ashworth M, Lee SI and Sierzant TL (1991) Felbamate for partial seizures: Results of a controlled clinical trial. Neurology 41:1785-1789.
11. 2+ and other ligands of the NMDA receptor-cation channel complex. Eur J Pharmacol 151:157-158.
12. McBain CJ and Mayer ML (1994) N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 74:723-760.
13. McCabe RT, Wasterlain CG, Kucharczyk N, Sofia RD and Vogel JR (1993) Evidence for anticonvulsant and neuroprotectant action of felbamate mediated by strychnine-insensitive glycine receptors. J Pharmacol Exp Ther 264:1248-1252.
14. 3H]glycine binding sites in rat brain by quantitative receptor autoradiography. Neuroscience 35:653-668.
15. Monaghan DT, Bridges RJ and Cotman CW (1989) The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402.
16. 3H]L-glutamate. Exp Brain Res 86:652-662.
17. Perhach JL, Weliky I, Newton JJ, Sofia RD, Romanyshyn WM and Arndt WF (1986) Felbamate, New Anticonvulsant Drugs (Meldrum BS and Porter RJ eds) pp 117-123, John Libbey, London.
18. 3H]1-Aminocyclopropanecarboxylic acid, a novel probe for strychnine-insensitive glycine receptors. Eur J Pharmacol Mol Pharmacol 291:221-227.
19. Porter RJ (1989) Mechanisms of action of new antiepileptic drugs. Epilepsia 30(Suppl 1):S29-S34.
20. Pullan LM and Powel RJ (1991) Spermine reciprocally changes the affinity of NMDA receptor agonists and antagonists. Eur J Pharmacol Mol Pharmacol 207:173-174.
21. 3H]-MK 801 binding to the N-methyl-D-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites. J Pharmacol Exp Ther 247:1025-1031.
22. A receptors. Ann Neurol 35:229-234.
23. Sacaan AI and Johnson KM (1989) Spermine enhances binding to the glycine site associated with the N-methyl-D-aspartate receptor complex. Mol Pharmacol 36: 836-839.
24. Sachdeo RC, Kramer LD, Rosenberg A and Sachdeo S (1992) Felbamate monotherapy: Controlled trial in patients with partial onset seizures. Ann Neurol 32:386-392.
25. Sofia RD, Kramer L, Perhach JL and Rosenberg A (1991) Felbamate. Epilepsy Res (Suppl 3):103-108.
26. Subramaniam S, Rho JM, Penix L, Donevan SD, Fielding RP and Rogawski MA (1995) Felbamate block of the N-methyl-D-aspartate receptor. J Pharmacol Exp Ther 273:878-886.
27. Swinyard EA, Sofia RD and Kupferberg HJ (1986) Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats. Epilepsia 27:27-34.
28. +2 concentration. Eur J Pharmacol 289:229-233.
29. The Felbamate Study Group in Lennox-Gastaut Syndrome (1993) Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 328:29-33.
30. Theodore WH, Raubertas RF, Porter RJ, Nice F, Devinsky O, Reeves P, Bromfield E, Ito B and Balish M (1991) Felbamate: A clinical trial for complex partial seizures. Epilepsia 32:392-397.
31. Wallis RA and Panizzon KL (1993) Glycine reversal of felbamate hypoxic protection. NeuroReport 4:951-954.
32. Wallis RA, Panizzon KL, Fairchild MD and Wasterlain CG (1992) Protective effects of felbamate against hypoxia in the rat hippocampal slice. Stroke 23:547-551.
33. 3H]5,7 dichlorokynurenic acid to identify strychnine-insensitive glycine receptors in human postmortem brain. Brain Res Bull 35:205-209.
34. Wamsley JK, Sofia RD, Faull RLM, Narang N, Ary T, Gan, S-D and McCabe RT (1994) Felbamate: interaction with glycine receptors in human cerebral cortex. Proc West Pharmacol Soc 37:81-83.
35. Wasterlain CG, Adams LM, Hattori H and Schwartz PH (1992) Felbamate reduces hypoxic-ischemic brain damage in vivo. Eur J Pharmacol 212:275-278.
36. White HS, Wolf HH, Swinyard EA, Skeen GA and Sofia RD (1992) A neuropharmacologic evaluation of felbamate as a novel anticonvulsant. Epilepsia 33:564-572.
37. White HS, Harmsworth WL, Sofia RD and Wolf HH (1995) Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Res 20:41-48.
38. Wong EHF and Kemp JA (1991) Sites for antagonism on the N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol 31:401-425.
39. 3H]MK 801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274-281.